Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells

por Zemanova, Jana, Hylse, Ondrej, Collakova, Jana, Vesely, Pavel, Oltova, Alexandra, Borsky, Marek, Zaprazna, Kristina, Kasparkova, Marie, Janovska, Pavlina, Verner, Jan, Kohoutek, Jiri, Dzimkova, Marta, Bryja, Vitezslav, Jaskova, Zuzana, Brychtova, Yvona, Paruch, Kamil, Trbusek, Martin
Publicado 2016

Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells

por Boudny, Miroslav, Zemanova, Jana, Khirsariya, Prashant, Borsky, Marek, Verner, Jan, Cerna, Jana, Oltova, Alexandra, Seda, Vaclav, Mraz, Marek, Jaros, Josef, Jaskova, Zuzana, Spunarova, Michaela, Brychtova, Yvona, Soucek, Karel, Drapela, Stanislav, Kasparkova, Marie, Mayer, Jiri, Paruch, Kamil, Trbusek, Martin
Publicado 2019